Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 83703-551

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 83703-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bamboo Us Bidco Lcc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

Chemical structure diagram of cyclophosphamide including elements oxygen, phosphorus, nitrogen, chlorine, and a hydrate component, depicting its molecular composition.*

FDA Label Image

Cyclophosphamide Premier Representative Container 10019-943-25 (Image 02)

Cyclophosphamide for Injection, USP 500 mg per vial powder for solution label. It states the product is a cytotoxic agent for single dose, sterile, non-pyrogenic, parenteral use. The label includes manufacturer information as Baxter Healthcare Corporation, Deerfield, IL, and indicates the product is made in Germany. Directions for reconstitution for IV infusion and direct injection use are also visible.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-943-01 1 Of 2 (Image 03)

Cyclophosphamide for Injection, USP 500 mg/vial powder for solution label. It is intended for intravenous or direct injection use and must be diluted before administration. The single-dose vial is manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, and made in Germany. The label includes instructions for preparation and storage, noting it as a cytotoxic agent.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-943-01 2 Of 2 (Image 04)

Packaging label for Cyclophosphamide for Injection, USP, 500 mg per vial. The label specifies use for intravenous infusion or direct injection and indicates it is a single-dose vial. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA, with product origin in Germany. The label includes NDC 10019-943-01 and trademark information for PremierProRx.*

FDA Label Image

Cyclophosphamide Premier Representative Container Label 10019-944-50 (Image 05)

Label for Cyclophosphamide for Injection, USP 1 gram/50 mL powder for solution by Baxter Healthcare Corporation, Deerfield, IL, USA. It is a cytotoxic agent for single dose use, sterile, non-pyrogenic, for parenteral administration. Instructions include adding 50 mL sterile water for IV infusion or 50 mL 0.9% sodium chloride injection for direct injection, with shaking to dissolve. Made in Germany.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-944-01 1 Of 2 (Image 06)

Packaging label for Cyclophosphamide for Injection, USP, 1 gram per vial. The label indicates the product is for intravenous or direct injection use and must be diluted. It features the Baxter Healthcare Corporation brand and notes the product is a single-dose vial manufactured in Germany. Instructions mention diluting in sterile water or sodium chloride injection and storage at or below 25°C.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-944-01 2 Of 2 (Image 07)

Packaging label for Cyclophosphamide for Injection, USP, 1 gram per vial, a powder for solution by Baxter Healthcare Corporation. The label states the drug must be diluted for intravenous infusion or direct injection and contains one single-dose vial. The label includes the NDC 10019-944-01 and indicates the product is made in Germany under the trademark PremierProRx®.*

FDA Label Image

Cyclophosphamide Premier Representative Container Label 10019-945-10 (Image 08)

Label for Cyclophosphamide injection, USP, 2 gram per vial powder for solution. It is a cytotoxic agent supplied for single dose use and sterile, non-pyrogenic for parenteral administration. The label includes instructions for reconstitution for IV infusion or direct injection with specific diluents. Manufactured by Baxter Healthcare Corporation in Deerfield, IL, made in Germany.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-945-01 1 Of 2 (Image 09)

Packaging label for Cyclophosphamide for Injection, USP 2 gram/vial, a powder for solution injection by intravenous or direct injection. The label indicates it must be diluted for use, is for single dose use, and is manufactured by Baxter Healthcare Corporation. It includes dosing instructions and storage conditions, noting the product is a cytotoxic agent.*

FDA Label Image

Cyclophosphamide Premier Pro Representative Carton Label 10019-945-01 2 Of 2 (Image 10)

Label for Cyclophosphamide for Injection, USP, 2 grams per vial. The label indicates it is for intravenous infusion or direct injection use. Manufactured by Baxter Healthcare Corporation, Deerfield, IL, USA, made in Germany. The label includes dosage form as injection, powder for solution, single-dose vial, and the NDC number 10019-945-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.